Advanced Therapy Showcase- Tokyo

Life Science Innovation Network Japan (LINK-J)’s virtual partnering event “Advanced Therapy Showcase in Tokyo #1 (ATST#1) is taking place on Thursday the 21st of January 2021

Registration deadline from Monday, November 30 to Friday, December 18, 2020 (see the attached updated event flyer).

Besides that, Tier 1 now counts six companies registered from Oceania, Europe and Asia, along with Tier 2 and Tier 3 registrations gradually catching up, and the plenary sessions being loaded with cerebrated KOLs as keynote speakers.

Further details can be found here  Advanced Therapy Showcase in Tokyo #1 (ATST#1). and registration is via this link

Companies and reserachers working within Advanced Therapies are welcome with those already registered working within Cell & Gene Therapy, Regenerative Medicine across Europe and Asia

Speakers include:

• Hideyuki Okano, Chairman of the Board, LINK-J / Dean, Keio University Graduate School of Medicine Professor, Department of Physiology, and
• Yoshitsugu, Shitaka, Representative Director, Vice Chairperson Forum for Innovative Regenerative Medicine (FIRM) / President of Astellas institute for Regenerative Medicine (AIRM).

Furthermore, the following distinguished speakers have committed to deliver keynotes;

• Steven A. Goldman, URMC Distinguished Professor of Neurology and Neuroscience, Co-Director, Center for Translational Neuromedicine, University of Rochester Medical Center,
• Michael Lehmicke, Director, Science & Industry Affairs, ARM, and
• tbd from Cell and Gene Therapy Catapult.

Life Science Innovation Network Japan (LINK-J)’s virtual partnering event “Advanced Therapy Showcase in Tokyo #1 (ATST#1)” is taking place on Thursday the 21^st of January. Further details can be found here and registration is via this link. Registration is open until the 18^th of December

Companies and academics working with Advanced Therapies including cell and gene therapy and regenerative medicine from across Asia, Oceania and Europe are already registered with opportunities available for companies and academics working within this area to present as well as partner.

Keynote speakers include:

• Hideyuki Okano, Chairman of the Board, LINK-J / Dean, Keio University Graduate School of Medicine Professor, Department of Physiology, and
• Yoshitsugu, Shitaka, Representative Director, Vice Chairperson Forum for Innovative Regenerative Medicine (FIRM) / President of Astellas institute for Regenerative Medicine (AIRM).
• Steven A. Goldman, URMC Distinguished Professor of Neurology and Neuroscience, Co-Director, Center for Translational Neuromedicine, University of Rochester Medical Center,
• Michael Lehmicke, Director, Science & Industry Affairs, ARM,
• tbd from Cell and Gene Therapy Catapult.